Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2019 Aug 26;57(9):e00114-19. doi: 10.1128/JCM.00114-19

The Brief Case: Bartonella henselae Endocarditis—a Case of Delayed Diagnosis

Kyle G Rodino a,#, Eric Stone b,#, Omar Abu Saleh b, Elitza S Theel a,
Editor: Carey-Ann D Burnhamc
PMCID: PMC6711904  PMID: 31451567

CASE

A 54-year-old male presented to an outside institution with a 2-month history of myalgia, headaches, 10-pound weight loss, fever, and night sweats. His past medical history was notable for rheumatic heart disease and placement of a bioprosthetic aortic valve 7 years prior. The patient was from Iowa, where he previously worked as a roofer, lived near many cattle farms, had a pet dog and cat, and frequently went fishing along the Mississippi river. On presentation, the patient had lower-extremity edema and his creatinine was elevated to 3.2 mg/dl (normal range, 0.59 to 1.04 mg/dl). Transthoracic echocardiogram (TTE) showed a stenotic and calcified aortic valve. Urinalysis demonstrated dysmorphic erythrocytes, and blood cultures drawn prior to initiation of antibiotics remained negative. Further laboratory analysis demonstrated an erythrocyte sedimentation rate (ESR) of 109 mm/ h (normal range, 0 to 29 mm/ h) and markers of vasculitis with a positive cytoplasmic antineutrophil cytoplasmic antibody (c-ANCA) with a titer of 1:256 and positive antiproteinase 3 (anti-PR3) levels of >8 U. Screening tests for HIV, hepatitis C virus, hepatitis B virus, and latent tuberculosis by an interferon gamma release assay were all negative. The patient initially responded to a 2-week course of prednisone; however, within 1 month he experienced additional fevers, weight loss, fatigue, malaise, and further worsening of his renal function. The patient was empirically treated with intravenous (IV) vancomycin and ceftriaxone for these symptoms. A renal biopsy was performed and interpreted as consistent with postinfectious glomerulonephropathy.

The patient was subsequently transferred to our medical center for further evaluation. Serologic testing for Blastomyces dermatitidis, Histoplasma capsulatum, Coccidioides immitis/Coccidioides posadasii, and Brucella species were all negative. Notably, the patient was seropositive for the following pathogens: spotted fever group Rickettsia with an IgG titer of 1:256, Coxiella burnetii phase II IgG titer of 1:256 (all other C. burnetii IgM and IgG titers were less than 1:16), Bartonella quintana IgG titer of 1:512 and an IgM titer of <1:20, a Bartonella henselae IgG titer of 1:32,768, and an IgM titer of <1:20. Bartonella species and C. burnetii real-time PCR (RT-PCR) on blood were negative. A transesophageal echocardiogram (TEE) demonstrated a stenotic aortic valve with thickened leaflets and a calcific, mobile mass. Valvular biopsy was not performed. Based on the results above, a diagnosis of B. henselae endocarditis was established. The patient was treated with oral doxycycline, IV ceftriaxone, and gentamicin for 2 weeks, followed by an additional 4 weeks of oral doxycycline and IV ceftriaxone, and remains on oral doxycycline indefinitely. One year after diagnosis, the patient is without further cardiovascular complications or need for surgery, and his B. henselae IgG titer has declined to 1:2,048. The patient was advised to have pets tested and treated for fleas.

DISCUSSION

Bartonella spp. are short, fastidious, Gram-negative coccobacilli transmitted to humans via either an insect vector or cats, depending on the species. While upwards of 30 species have been identified, 12 have been linked to human infection, among which three are most commonly encountered clinically. These include the causative agents of Oroya fever (Bartonella bacilliformis), trench fever (Bartonella quintana), and cat scratch disease (CSD; Bartonella henselae) (1). Oroya fever is endemic to the Andes Mountains and limited to specific elevations inhabited by its vector, the sand fly. This acute form of B. bacilliformis infection presents as a febrile illness with marked anemia (1). The chronic form of B. bacilliformis infection, verruga peruana, is more common among persons native to the region where it is endemic and presents as nodular skin lesions months after initial infection (1). Trench fever draws its name from World War I, when more than a million soldiers fighting in close quarters developed a recurrent episodic febrile illness associated with bone pain, headache, and rash, transmitted by lice. Modern outbreaks are associated with poor living conditions among the homeless population and in refugee camps (1, 2) Transmission of B. henselae is associated with cats and cat fleas. Weeks after a scratch or bite, a pustule will form at the site of inoculation with associated localized lymphadenopathy. Commonly, this is a self-limiting disease (1, 3). B. henselae and B. quintana have a global distribution and are associated with culture-negative endocarditis in approximately 12% to 28% of cases. Bartonella spp. are the second most common cause of culture-negative endocarditis, after Coxiella burnetii (4, 5). Definitive diagnosis of Bartonella endocarditis can be challenging and typically involves consideration of clinical presentation, echocardiography findings, and laboratory results with respect to the modified Duke criteria for infective endocarditis (6). In a study of 101 patients with Bartonella endocarditis, echocardiography findings included the presence of vegetation in 90% of cases, with a predominance of aortic valve involvement identified in 59% of patients, whereas multiple valves were involved in only 18% of the cohort (7).

Serology is the single most informative, noninvasive test to aid in the diagnosis of Bartonella endocarditis. Immunofluorescence assays (IFAs) and enzyme-linked immunosorbent assays (ELISAs) for detection of IgG and IgM are commercially available for B. quintana and B. henselae, although classically, IFA is preferred due to its better performance characteristics and ability to provide semiquantitative titers. IFA results of ≥1:64 for IgG-class antibodies to B. henselae are considered positive, with sensitivity ranges of 88% to 98% reported across different assays (8). Notably, however, seroprevalence studies performed across multiple countries have shown that anywhere from 3% to 30% of otherwise healthy individuals may be seropositive for IgG-class antibodies to B. henselae using this threshold titer. However, the majority of these positive results are at titers of ≤1:128, and for this reason a single-time-point, low-level positive IgG titer should be interpreted with caution (Table 1). Reasons for this reactivity are likely due to prior exposure to the bacterium or possibly are the result of cross-reactivity with other Bartonella spp. or organisms, including C. burnetii, Chlamydophila pneumoniae, or spotted fever group Rickettsia. Given these findings, IgG titers of ≥1:256 and/or a 4-fold rise in IgG antibodies between acute and convalescent-phase samples are considered indicative of current or recent infection. Notably, patients with Bartonella endocarditis often present with high IgG titers, and prior studies have demonstrated that IgG levels of ≥1:800 correlate with endocarditis in 94% of cases (9). Assays for detection of IgM-class antibodies against B. henselae are considerably less sensitive (range, 50% to 62%), with titers of ≥1:20 considered positive (8, 10). IgM-class antibodies to Bartonella species are typically present early in infection and wane 8 to 10 weeks thereafter, suggesting that IgM testing may not be helpful during later stages of disease (8). The reported specificity of IgM assays is high (95%), and notably higher than that reported for IgG assays (69% to 89%), although false-positive results may still occur with C. burnettii and C. pneumoniae infections (11). Notably, a positive anti-Bartonella IgM result alone should be considered cautiously and interpreted alongside the timing of the potential exposure and duration of patient symptoms. Convalescent testing of a new specimen collected 2 to 3 weeks later is recommended to show seroconversion of anti-Bartonella IgG, to help rule out a false-positive IgM result.

TABLE 1.

Advantages and limitations of methods for detection of Bartonella species endocarditis

Method Advantages Limitations
Serology High sensitivity in cases of endocarditis False positives due to cross-reactivity
Seroconversion or increasing IgG antibody titers indicate active infection Mildly elevated baseline IgG antibody titers (<1:128) in the general population
Noninvasive
Bartonella-specific RT-PCR High sensitivity and specificity from tissue Low sensitivity from blood
16S rRNA PCR and sequencing Broad-range bacterial DNA amplification reduces the need for targeted pathogen testing Lower sensitivity than pathogen-specific PCR
Risk of identifying a contaminant
Histopathology/immunohistochemistry Allows for assessment across spectrum of infectious diseases Lack of pathogen-specific stains
Demonstrates involvement of specific tissue Background/nonspecific staining makes interpretation difficult
Culture Definitive diagnosis Poor sensitivity from all specimen types
Indicates active infection

Historically, culture of both blood and heart valve tissue were the preferred microbiologic methods employed for suspected Bartonella endocarditis. Even with specialized collection and culture procedures however, including plating on fresh media and incubation in 5% CO2 at 35 to 37°C for up to 21 days, recovery was poor (Table 1) (12). For this reason, culture has largely been supplanted with nucleic acid amplification tests (NAATs), including Bartonella-specific real-time PCR (RT-PCR) assays and/or broad-range bacterial 16S PCR and sequencing (9, 13). While superior to culture, these new methods are not without their own set of limitations, as pretest probability varies greatly with specimen type (4). One study of patients with confirmed Bartonella endocarditis showed just 33% sensitivity using a Bartonella-specific RT-PCR from blood (9). While less than ideal, this is an improvement over recovery of B. henselae in blood cultures, which is approximately 20% among patients with endocarditis (9). Bartonella-specific RT-PCR demonstrated improved performance from explanted valve tissue, with a sensitivity of 92% compared to 60% sensitivity using broad-range PCR and sequencing and to just 30% sensitivity achieved using traditional culture methods (9). While positive NAAT results provide definitive evidence of infection with Bartonella spp., the highly variable negative predictive value of these assays warrants cautious reliance on a negative result when clinical suspicion remains high (Table 1).

Histopathology of valve tissue commonly accompanies microbiological testing when biopsy is performed. In cases of Bartonella endocarditis, visualization of the organism in tissue can be difficult, especially with prior antibiotic treatment. Bartonella spp. are not easily observed with routine stains, such as hematoxylin and eosin (H&E), Grocott-Gomori methenamine silver (GMS), or Gram stain (Table 1). Silver stains, such as Warthin-Starry, Steiner, or Dieterle, are preferred, but can be technically challenging to interpret due to high background and nonspecific silver deposition on reticulin or other fibers, mimicking the appearance of coccobacilli (14). Species-specific immunohistochemical stains are also available in specialized laboratories but suffer from poor sensitivity (9).

Finally, the positive c-ANCA result in this case deserves mention, as this finding is not uncommon in cases of Bartonella endocarditis. A 2016 case series of 50 patients demonstrated that among 24% of patients diagnosed with any infective endocarditis, 84% had a positive c-ANCA result and 74% of c-ANCA positive patients with infective endocarditis demonstrated renal failure (15). Furthermore, a 2014 case report and literature review of Bartonella endocarditis cases reported that 50% of the eight reviewed cases were c-ANCA positive (16). Although further research is needed to correlate c-ANCA results with infective endocarditis, a positive c-ANCA result may prompt providers to consider culture-negative endocarditis sooner, alongside a detailed clinical assessment and targeted diagnostic testing.

SELF-ASSESSMENT QUESTIONS

  1. Which of the following is the most sensitive noninvasive microbiologic assay for detection of suspected Bartonella spp. endocarditis?
    • a.
      Blood culture
    • b.
      Culture of heart valve tissue
    • c.
      Bartonella sp. IgG-specific serologic testing
    • d.
      Broad-range 16S PCR and sequencing from heart valve tissue
  1. A 63-year-old male originally from Brazil and now living in a homeless shelter presents to the emergency department with a fever, headache, rash, and bone pain in the shins, neck, and back. On examination, lice are visible on the patient’s clothes and hospital bed sheets. Which of the following is the most likely causative organism?
    • a.
      Bartonella henselae
    • b.
      Bartonella quintana
    • c.
      Bartonella bacilliformis
    • d.
      Bartonella alsatica
  1. Antibodies to which of the following pathogens can lead to cross-reactivity on serologic assays for detection of Bartonella sp. antibodies?
    • a.
      Anaplasma phagocytophilum
    • b.
      Brucella abortus
    • c.
      Coxiella burnetii
    • d.
      Treponema pallidum

For answers to the self-assessment questions and take-home points, see https://doi.org/10.1128/JCM.00123-19 in this issue.

REFERENCES

  • 1.Jorgensen JH, Pfaller MA, Carroll KC. 2015. Manual of clinical microbiology, 11th ed, vol 1 ASM Press, Washington, DC. [Google Scholar]
  • 2.Brouqui P, Houpikian P, Dupont HT, Toubiana P, Obadia Y, Lafay V, Raoult D. 1996. Survey of the seroprevalence of Bartonella quintana in homeless people. Clin Infect Dis 23:756–759. doi: 10.1093/clinids/23.4.756. [DOI] [PubMed] [Google Scholar]
  • 3.Moriarty RA, Margileth AM. 1987. Cat scratch disease. Infect Dis Clin North Am 1:575–590. [PubMed] [Google Scholar]
  • 4.Liesman RM, Pritt BS, Maleszewski JJ, Patel R. 2017. Laboratory diagnosis of infective endocarditis. J Clin Microbiol 55:2599–2608. doi: 10.1128/JCM.00635-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, Maurin M, Celard M, Mainardi JL, Caus T, Collart F, Habib G, Raoult D. 2010. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 51:131–140. doi: 10.1086/653675. [DOI] [PubMed] [Google Scholar]
  • 6.Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638. doi: 10.1086/313753. [DOI] [PubMed] [Google Scholar]
  • 7.Raoult D, Fournier PE, Vandenesch F, Mainardi JL, Eykyn SJ, Nash J, James E, Benoit-Lemercier C, Marrie TJ. 2003. Outcome and treatment of Bartonella endocarditis. Arch Intern Med 163:226–230. doi: 10.1001/archinte.163.2.226. [DOI] [PubMed] [Google Scholar]
  • 8.Vermeulen MJ, Herremans M, Verbakel H, Bergmans AM, Roord JJ, van Dijken PJ, Peeters MF. 2007. Serological testing for Bartonella henselae infections in The Netherlands: clinical evaluation of immunofluorescence assay and ELISA. Clin Microbiol Infect 13:627–634. doi: 10.1111/j.1469-0691.2007.01700.x. [DOI] [PubMed] [Google Scholar]
  • 9.Edouard S, Nabet C, Lepidi H, Fournier PE, Raoult D. 2015. Bartonella, a common cause of endocarditis: a report on 106 cases and review. J Clin Microbiol 53:824–829. doi: 10.1128/JCM.02827-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Maurin M, Eb F, Etienne J, Raoult D. 1997. Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol 35:2283–2287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vermeulen MJ, Verbakel H, Notermans DW, Reimerink JH, Peeters MF. 2010. Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology. J Med Microbiol 59:743–745. doi: 10.1099/jmm.0.015248-0. [DOI] [PubMed] [Google Scholar]
  • 12.Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, Gonzalez MD, Jerris RC, Kehl SC, Patel R, Pritt BS, Richter SS, Robinson-Dunn B, Schwartzman JD, Snyder JW, Telford S 3rd, Theel ES, Thomson RB Jr, Weinstein MP, Yao JD. 2018. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 67:813–816. doi: 10.1093/cid/ciy584. [DOI] [PubMed] [Google Scholar]
  • 13.Morel AS, Dubourg G, Prudent E, Edouard S, Gouriet F, Casalta JP, Fenollar F, Fournier PE, Drancourt M, Raoult D. 2015. Complementarity between targeted real-time specific PCR and conventional broad-range 16S rDNA PCR in the syndrome-driven diagnosis of infectious diseases. Eur J Clin Microbiol Infect Dis 34:561–570. doi: 10.1007/s10096-014-2263-z. [DOI] [PubMed] [Google Scholar]
  • 14.Pritt BS. 2018. Atlas of fundamental infectious disease histopathology: a guide for daily practice. College of American Pathologists, Northfield, IL. [Google Scholar]
  • 15.Langlois V, Lesourd A, Girszyn N, Menard JF, Levesque H, Caron F, Marie I. 2016. Antineutrophil cytoplasmic antibodies associated with infective endocarditis. Medicine (Baltimore) 95:e2564. doi: 10.1097/MD.0000000000002564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Khalighi MA, Nguyen S, Wiedeman JA, Palma Diaz MF. 2014. Bartonella endocarditis-associated glomerulonephritis: a case report and review of the literature. Am J Kidney Dis 63:1060–1065. doi: 10.1053/j.ajkd.2013.10.058. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES